The heterometallic optical complexes [Cu2Co(S,S(+)cpse)3(H2O)3]·4H2O (1) and [Cu2Ni(S,S(+)cpse)3(H2O)3]·10H2O (2) were obtained from the mononuclear copper(II) compound by the addition of nickel(II) or cobalt(II) chlorides, where (H2cpse) is the acetyl amino alcohol derivative N-[2-hydroxy-1(R)-methyl-2(R)-phenylethyl]-N-methylglycine. In comparison with the homotrinuclear copper(II) compound [Cu3(S,S(+)cpse)3(H2O)3]·8H2O reported previously, the substitution of a copper(II) atom by one cobalt(II) ion gave place to a heterotrinuclear compound1, which presents ferromagnetic-antiferromagnetic behaviour. When substituting a copper(II) by a nickel(II) ion, the trinuclear compound2showed an antiferromagnetic coupling. The magnetic behaviour of the heterotrinuclear compounds is driven by the nature of the metal ion which was introduced in the copper(II) triangular array. The ligand and its coordination compounds were characterized by IR, UV-Vis-NIR. Their chemical was confirmed by photoelectron spectroscopy (XPS).

No abstract

In this work, the degradation of the pharmaceutical losartan, in simulated fresh urine (which was considered because urine is the main excretion route for this compound) by sonochemistry and UVC/H2O2 individually, was studied. Initially, special attention was paid to the degrading action of the processes. Then, theoretical analyses on Fukui function indices, to determine electron-rich regions on the pharmaceutical susceptible to attacks by the hydroxyl radical, were performed. Afterward, the ability of the processes to mineralize losartan and remove the phyto-toxicity was tested. It was found that in the sonochemical treatment, hydroxyl radicals played the main degrading role. In turn, in UVC/H2O2, both the light and hydroxyl radical eliminated the target contaminant. The sonochemical system showed the lowest interference for the elimination of losartan in the fresh urine. It was established that atoms in the imidazole of the contaminant were the moieties most prone to primary transformations by radicals. This was coincident with the initial degradation products coming from the processes action. Although both processes exhibited low mineralizing ability toward losartan, the sonochemical treatment converted losartan into nonphytotoxic products. This research presents relevant results on the elimination of a representative pharmaceutical in fresh urine by two advanced oxidation processes.

No abstract